Peroxynitrite stimulates pulmonary artery endothelial and smooth muscle cell proliferation: Involvement of ERK and PKC

被引:31
作者
Agbani, E. O. [1 ]
Coats, P. [1 ]
Mills, A. [2 ]
Wadsworth, R. M. [1 ]
机构
[1] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0NR, Lanark, Scotland
[2] Univ Strathclyde, Dept Pure & Appl Chem, Glasgow G4 0NR, Lanark, Scotland
关键词
Pulmonary; Hypertension; Peroxynitrite; Endothelial cells; Smooth muscle cells; ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; NITRIC-OXIDE; HYPERTENSION; INHIBITOR; RECEPTOR; PATHWAY; RAF-1; RAS;
D O I
10.1016/j.pupt.2010.09.003
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Background: There is evidence that peroxynitrite is generated in pulmonary hypertension and we have therefore investigated whether peroxynitrite can cause proliferation of pulmonary artery cells. Methods: Bovine pulmonary artery endothelial (PAEC) and smooth muscle cells (PASMC) were exposed to peroxynitrite solution or to the peroxynitrite generating compound, 3-morpholinosydnonimine (SIN-1). Vascular cell proliferation was determined by cell count and H-3-thymidine incorporation. Protein biochemistry was by western blot analysis. Results: Transient exposure to peroxynitrite stimulated the proliferation of PASMC (peroxynitrite 0.2 nM -2 mu M) and PAEC (peroxynitrite 0.2 mu M). Peroxynitrite 0.2 mu M stimulated DNA synthesis in PASMC cell by 200 +/- 22% and in PAEC by 137 +/- 4%. DNA synthesis in PAEC and PASMC was also stimulated by the peroxynitrite generator SIN-1 2 mu M. Cell proliferation was accompanied by activation of ERK, which peaked at 15 min and remained elevated for 12 h in PASMC. However peroxynitrite at the concentrations used in this study did not activate the stress pathways p38 mitogen activated protein kinase (MAPK) or Jun N-terminal kinase (JNK). Peroxynitrite-induced proliferation and ERK phosphorylation in PASMC were abolished by the peroxynitrite scavenger ebselen 5 mu M. Peroxynitrite-induced proliferation and extracellular signal-regulated kinase (ERK) phosphorylation in PASMC was prevented by selective inhibitors of MAP kinase kinase (MEK) (U0126 5 mu M, PD98059 50 mu M), Raf-1 (Raf-1 kinase inhibitor 10 mu M), Ras (FPT II and FPT III 10 mu M) and protein kinase C (PKC) (GF109203X 10 mu M). Inhibition of EGF or PDGF receptor signaling using AG-1296. AG-1478 or imatinib prevented peroxynitrite-induced cell proliferation and ERK phosphorylation in PASMC. Conclusion: Peroxynitrite can stimulate proliferation of pulmonary artery cells, involving ERK, PKC and EGF or PDGF receptors. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:100 / 109
页数:10
相关论文
共 53 条
[1]
PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO [J].
ALESSI, DR ;
CUENDA, A ;
COHEN, P ;
DUDLEY, DT ;
SALTIEL, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27489-27494
[2]
RAF MEETS RAS - COMPLETING THE FRAMEWORK OF A SIGNAL-TRANSDUCTION PATHWAY [J].
AVRUCH, J ;
ZHANG, XF ;
KYRIAKIS, JM .
TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (07) :279-283
[3]
Peroxynitrite activates mitogen-activated protein kinase (MAPK) via a MEK-independent pathway: a role for protein kinase C [J].
Bapat, S ;
Verkleij, A ;
Post, JA .
FEBS LETTERS, 2001, 499 (1-2) :21-26
[4]
Oxidative stress in severe pulmonary hypertension [J].
Bowers, R ;
Cool, C ;
Murphy, RC ;
Tuder, RM ;
Hopken, MW ;
Flores, SC ;
Voelkel, NF .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 169 (06) :764-769
[5]
CLAVREUL N, 2006, FASEB J
[6]
Inhibition of non-Ras protein farnesylation reduces in-stent restenosis [J].
Coats, Paul ;
Kennedy, Simon ;
Pyne, Susan ;
Wainwright, Cherry L. ;
Wadsworth, Roger A. .
ATHEROSCLEROSIS, 2008, 197 (02) :515-523
[7]
Accumulation of nitrotyrosine correlates with endothelial NO synthase in pulmonary resistance arteries during chronic hypoxia in the rat [J].
Demiryürek, MR ;
Karamsetty, MR ;
McPhaden, AR ;
Wadsworth, RM ;
Kane, KA ;
MacLean, MR .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2000, 13 (04) :157-165
[8]
DeSilva DR, 1998, J IMMUNOL, V160, P4175
[9]
Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia [J].
Druker, BJ ;
Lydon, NB .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (01) :3-7
[10]
RETRACTED: Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent mechanism in endothelial cells (Retracted article. See vol. 31, pg. 421, 2017) [J].
El-Remessy, A. B. ;
Al-Shabrawey, M. ;
Platt, D. H. ;
Bartoli, M. ;
Behzadian, M. A. ;
Ghaly, N. ;
Tsai, N. ;
Motamed, K. ;
Caldwell, R. B. .
FASEB JOURNAL, 2007, 21 (10) :2528-2539